Post-approval studies (Phase 4)UnknownNCT05075070
What this trial is testing
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected
Who this might be right for
COVID-19HIV Infections
China National Biotec Group Company Limited 400